Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-20

Study Completion Date

2030-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy

NCT05005650

Ovarian Cancer Stage IV Lymph Node Metastases

COMPLETED

Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision

NCT06279299

Rectal Neuroendocrine Neoplasm

RECRUITING NA

Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer

NCT01946672

Gynaecological Malignant Tumours With Indication of Pelvic Lymphadenectomy

COMPLETED PHASE4

Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate

NCT04802993

Pancreatic Ductal Adenocarcinoma

COMPLETED

The Role of Vascular Reconstruction in the Setting of Pelvic Exenteration

NCT04948879

Vascular Reconstruction in Pelvic Exenterative Surgery

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Cancer Ovarian Cancer (OvCa) Ovarian Adenocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ovarian cancer patients

resection of infundibulopelvic ligament

Intervention Type OTHER

Therefore, this study also aims to perform bilateral infundibulopelvic ligament resection (at least 8 cm in length) during surgery for ovarian cancer patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

resection of infundibulopelvic ligament

Therefore, this study also aims to perform bilateral infundibulopelvic ligament resection (at least 8 cm in length) during surgery for ovarian cancer patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.

* FIGO 2014 stage IA-IVB.
* Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
* Patients with no residual disease after surgery.
* Patients with ECOG performance status 0-1.

Exclusion Criteria

* ◦ Patients without epithelial ovarian cancer.

* Patients with ECOG 2-4.
* Patients who do not consent to participate in the study.
* Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No